Our lawyers have extensive experience with regard to the drug reimbursement. Counsellor Oskar Luty and Counsellor Marcin Flak co-authored the first commentary on reimbursement rules that came into force in 2012.

For many years, our lawyers have been providing advisory services in such areas as:

  • assessing refundability chances of medicinal products and preparing reimbursement applications,
  • determining the pricing policy,
  • negotiating applications before the Economic Commission of the Ministry of Health, including negotiating risk-sharing instruments,
  • solving legal problems related to the reimbursement, regarding the application of prices, advertising and promotional instruments, building information policy on the availability of reimbursable products, etc.,
  • building and negotiating drug schemes,
  • building an access strategy to public financing outside the drug reimbursement regime (guaranteed benefits).